|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4260 - 0.4260|
|52 Week Range||0.4100 - 2.1000|
|Beta (5Y Monthly)||1.49|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar. 01, 2022 - Mar. 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
Ampio (AMPE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The heavy selling pressure might have exhausted for Ampio (AMPE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.